Table 5.
Outcomes (cohort studies).
Study | Duration of Hospital Admission | Recurrence of the Bacteraemia or Symptoms within 60 Days | Adverse Reaction |
---|---|---|---|
Patel, McKissic et al. 2014 [23] | Ceftriaxone mean 28 days (SD 44); Nafcillin/cefazolin/vancomycin group mean 36 days (SD 43) (p = 0.41). | Ceftriaxone 11.9% (5/42) standard antibiotic 11.7 (6/51) | Ceftriaxone 7.1% (3/42) Standard antibiotic 1.9% (1/51) |
Ibrahim et al. 2016 [26] | Ceftriaxone mean 2.7 days (range 1–10); Flucloxacillin 2.7 days (range 1–8) | Ceftriaxone 4.9% (2/41) Flucloxacillin 2.9% (3/103) | Not reported |
Winans et al. 2013 [25] | Ceftriaxone median 12 days (range 4–26) Cefazolin median 9 days (range 3–27) | Ceftriaxone 6.8% (3/44) Cefazolin 9.0% (7/78) | Ceftriaxone 2.27% (1/44) Cefazolin 5.1% (4/78) |
Wieland et al. 2012 [24] | Not reported | Not reported | Ceftriaxone 2.7% (2/74) Oxacillin 5% (2/40) |